Lamy Patrick
Insider CIK 1961273 · AKRO Senior VP, Commercial Strategy
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 84,904 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 382 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 11,096 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 48,679 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 64,182 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 26,832 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 3,059 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-07-01 | 2025-07-03 | 2,000 | $52.88 | $105.8K | 29,891 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-30 | 2025-07-02 | 193 | $23.87 | $4.6K | 31,891 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-20 | 2025-06-20 | 875 | $54.59 | $47.8K | 31,698 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-06-16 | 2025-06-20 | 2,000 | — | $0 | 64,182 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-16 | 2025-06-20 | 500 | $55.09 | $27.5K | 32,573 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-06-16 | 2025-06-20 | 2,000 | $19.87 | $39.7K | 34,573 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-16 | 2025-06-20 | 1,500 | $53.82 | $80.7K | 33,073 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-12 | 919 | $54.00 | $49.6K | 32,573 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-06-02 | 2025-06-04 | 4,000 | — | $0 | 66,182 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-02 | 2025-06-04 | 600 | $49.40 | $29.6K | 36,892 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-02 | 2025-06-04 | 3,300 | $50.46 | $166.5K | 33,592 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-02 | 2025-06-04 | 100 | $51.04 | $5.1K | 33,492 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-06-02 | 2025-06-04 | 4,000 | $19.87 | $79.5K | 37,492 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-05-22 | 2025-05-23 | 4,000 | — | $0 | 84,904 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-05-22 | 2025-05-23 | 4,000 | $50.00 | $200.0K | 33,492 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-05-22 | 2025-05-23 | 4,000 | $44.37 | $177.5K | 37,492 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-05-07 | 2025-05-09 | 8,000 | — | $0 | 70,182 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-05-07 | 2025-05-09 | 4,701 | $42.31 | $198.9K | 36,791 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-05-07 | 2025-05-09 | 8,000 | $19.87 | $159.0K | 41,492 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-05-07 | 2025-05-09 | 3,299 | $42.76 | $141.1K | 33,492 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-03-03 | 2025-03-05 | 1,000 | — | $0 | 78,182 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-03 | 2025-03-05 | 1,000 | $48.09 | $48.1K | 33,492 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-03-03 | 2025-03-05 | 1,000 | $19.87 | $19.9K | 34,492 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-27 | 2025-01-29 | 4,000 | — | $0 | 79,182 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-29 | 5,000 | $57.03 | $285.1K | 33,492 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-01-27 | 2025-01-29 | 4,000 | $19.87 | $79.5K | 38,492 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-12-31 | 2025-01-29 | 234 | $19.69 | $4.6K | 34,492 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-12-16 | 2024-12-18 | 52,100 | — | $0 | 52,100 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-16 | 2024-12-18 | 1,000 | $29.13 | $29.1K | 34,258 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-12-16 | 2024-12-18 | 17,400 | — | $0 | 35,258 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 925 | $30.79 | $28.5K | 17,858 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-06-28 | 2024-07-02 | 221 | $19.94 | $4.4K | 18,783 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-06-11 | 2024-06-13 | 569 | $22.64 | $12.9K | 18,562 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-12-08 | 2023-12-12 | 83,564 | — | $0 | 83,564 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2023-12-08 | 2023-12-12 | 18,570 | — | $0 | 18,570 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-01-10 | 2023-01-11 | 100,000 | — | $0 | 100,000 | SEC↗ |